NCT02372175View on ClinicalTrials.gov

Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Dengue
Interventions
BIOLOGICAL

Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)

Dengue subtype 1 Challenge Virus (DENV-1) strain 45AZ5 administered as a single injection.

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

State University of New York - Upstate Medical University

OTHER

lead

U.S. Army Medical Research and Development Command

FED

NCT02372175 - Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain | Biotech Hunter | Biotech Hunter